Loading clinical trials...
Loading clinical trials...
Medical Students' Evaluation of Dyslipidemia and LIPoprotein(a) Study (MEDLIP Study)
This cross-sectional study aims to determine the prevalence of elevated Lp(a) levels among volunteer medical students at the Faculty of Medicine, University Hospital of Ioannina, Greece. Data collected will include demographic information, family and medical history, as well as lifestyle habits, and the study aims to provide valuable insights into the prevalence of elevated Lp(a) among Greek medical students.
Lipoprotein(a) \[Lp(a)\] has emerged as a prevalent monogenetic cardiovascular risk factor globally. Despite its significance, clinical attention for elevated Lp(a) is suboptimal. This cross-sectional study aims to determine the prevalence of elevated Lp(a) levels among volunteer medical students at the Faculty of Medicine, University Hospital of Ioannina, Greece, as well as gather data on the demographic characteristics and medical history of this population. Statistical analysis will assess Lp(a) levels, prevalence, and associations with demographic and cardiovascular risk factors. The study aims to provide valuable insights into the prevalence of elevated Lp(a) among Greek medical students, emphasizing the importance of awareness, early diagnosis, and management of this cardiovascular risk factor.
Age
All ages
Sex
ALL
Healthy Volunteers
Yes
University Hospital of Ioannina
Ioannina, Ioannina, Greece
Start Date
June 1, 2024
Primary Completion Date
July 1, 2024
Completion Date
October 1, 2024
Last Updated
July 1, 2024
246
ESTIMATED participants
Measurement of Lp(a) levels
DIAGNOSTIC_TEST
Lead Sponsor
University of Ioannina
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions